BETA
Your AI-Trained Oncology Knowledge Connection!
Naveen Pemmaraju, MD, joins Rohit Gosain, MD, and Rahul Gosain, MD, to discuss diagnostic practices and prognostic factors for patients with myelofibrosis.
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Understanding Predictive Markers Drives Ruxolitinib Usage in Myelofibrosis
Unraveling Key Blood Cancer Takeaways From the 2025 SOHO Meeting
Impact of Posttransplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 Years and Older: An Update from BMT CTN 1703
Navigating AE Management for Cellular Therapy Across Hematologic Cancers
Exa-cel Exhibits Meaningful HRQoL Benefit in Severe Sickle Cell Disease
Rusfertide Earns FDA BTD for Erythrocytosis in Polycythemia Vera